Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Dumont

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Bulletin Du Cancer|December 5, 2009
[Cancer and spirituality: the young oncologists' point of view]Sophie Postel-Vinay, Sarah Dumont, Hélène Marijon
Bulletin Du Cancer|May 27, 2015
[Nab-paclitaxel]Daniel Lopez-Trabada Ataz, Sarah Dumont, Thierry André
Soins. Pediatrie, Puericulture|September 25, 2016
[Nursing coordination for adolescents and young adults in oncology]Loïc Dagorne, Tania Bruckner, Bruno Gaudry, et al.
Frontiers in Immunology|September 7, 2021
Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal TumorsMatthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, et al.
Annales De Pathologie|August 23, 2022
Erratum to "Sarcome avec transcrit de fusion EWSR1-PATZ1 Une nouvelle observation avec revue de la littérature" [Ann. Pathol. 41 (2021) 207-211/1513]Carine Ngo, Pierre Khneisser, Christina Kanaan, et al.
Bulletin Du Cancer|April 2, 2016
[What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?]Antoine Schernberg, Aurélien Marabelle, Christophe Massard, et al.
Annales De Pathologie|October 20, 2020
EWSR1-PATZ1 fusion sarcoma - A new case report and review of the literatureCarine Ngo, Pierre Khneisser, Christina Kanaan, et al.
BJC Reports|June 11, 2026
Improving cancer care while reducing its carbon footprint: GHG-mitigating strategies highlighted at ESMO 2025Matthieu Delaye, Paul Matte, Anthony Turpin, et al.
Cancer Treatment Reviews|November 24, 2018
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcomaTarek Assi, Joseph Kattan, Elie El Rassy, et al.
Cancer Medicine|January 16, 2021
Systematic review of phase-I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the researchArthur Felix, Pablo Berlanga, Maud Toulmonde, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Bulletin Du Cancer|December 5, 2009
[Cancer and spirituality: the young oncologists' point of view]Sophie Postel-Vinay, Sarah Dumont, Hélène Marijon
Bulletin Du Cancer|May 27, 2015
[Nab-paclitaxel]Daniel Lopez-Trabada Ataz, Sarah Dumont, Thierry André
Soins. Pediatrie, Puericulture|September 25, 2016
[Nursing coordination for adolescents and young adults in oncology]Loïc Dagorne, Tania Bruckner, Bruno Gaudry, et al.
Frontiers in Immunology|September 7, 2021
Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal TumorsMatthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, et al.
Annales De Pathologie|August 23, 2022
Erratum to "Sarcome avec transcrit de fusion EWSR1-PATZ1 Une nouvelle observation avec revue de la littérature" [Ann. Pathol. 41 (2021) 207-211/1513]Carine Ngo, Pierre Khneisser, Christina Kanaan, et al.
Bulletin Du Cancer|April 2, 2016
[What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?]Antoine Schernberg, Aurélien Marabelle, Christophe Massard, et al.
Annales De Pathologie|October 20, 2020
EWSR1-PATZ1 fusion sarcoma - A new case report and review of the literatureCarine Ngo, Pierre Khneisser, Christina Kanaan, et al.
BJC Reports|June 11, 2026
Improving cancer care while reducing its carbon footprint: GHG-mitigating strategies highlighted at ESMO 2025Matthieu Delaye, Paul Matte, Anthony Turpin, et al.
Cancer Treatment Reviews|November 24, 2018
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcomaTarek Assi, Joseph Kattan, Elie El Rassy, et al.
Cancer Medicine|January 16, 2021
Systematic review of phase-I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the researchArthur Felix, Pablo Berlanga, Maud Toulmonde, et al.
Pageof 4